Pacliaqualip 30Mg Injection

1. Product Introduction

Pacliaqualip 30mg Injection is an advanced chemotherapy medication that contains Paclitaxel, a powerful anti-cancer agent belonging to the class of taxanes. This medicine is specially formulated using nanotechnology-based lipid suspension (liposomal formulation), which enhances drug delivery to cancer cells and reduces toxicity to healthy tissues.

Paclitaxel works by interfering with the microtubule structures within cancer cells, thereby stopping their division and growth. It is widely used in the treatment of various solid tumors including ovarian, breast, lung, cervical, and pancreatic cancers. The 30mg dose of Pacliaqualip is generally used for patients who require a lower or fractionated dose depending on their body weight, cancer type, or tolerance.

Pacliaqualip is administered intravenously by a healthcare professional, typically in a hospital or chemotherapy clinic. The liposomal formulation may offer better tolerability compared to conventional Paclitaxel and is often preferred when patients are sensitive to standard solvents like Cremophor EL used in traditional formulations.

2. Uses of This Medicine

Pacliaqualip 30mg Injection is prescribed for the treatment of:

• Breast Cancer – especially in metastatic or recurrent cases, or following failure of other chemotherapy regimens.

• Ovarian Cancer – either as first-line treatment with platinum compounds or in recurrent disease.

• Non-Small Cell Lung Cancer (NSCLC) – particularly when surgery or radiation is not feasible.

• Pancreatic Cancer – often used in combination with other agents like gemcitabine.

• Cervical Cancer – in combination with other cytotoxic drugs.

• Kaposi’s Sarcoma (in AIDS patients) – for patients who do not respond to standard therapy.

This medicine is usually part of a combination chemotherapy protocol, meaning it’s given alongside other anti-cancer drugs to enhance efficacy.

3. Benefits of This Medicine

Pacliaqualip offers several key benefits in the treatment of cancer:

✅ Targeted Cancer Cell Kill: Paclitaxel targets cancer cells more selectively due to its microtubule-stabilizing activity, leading to effective tumor reduction.

✅ Improved Tolerability: The liposomal delivery reduces the use of solvents, potentially lowering the risk of hypersensitivity and side effects.

✅ Versatile Use: Effective against a wide range of cancers including breast, ovarian, lung, and pancreatic malignancies.

✅ Reduced Premedication Need: Some patients may require fewer premedications (like steroids and antihistamines) compared to traditional Paclitaxel.

✅ Potential for Fewer Infusion Reactions: The improved formulation may reduce the risk of severe allergic reactions, allowing smoother administration.

✅ Better Quality of Life: By slowing disease progression and reducing tumor burden, many patients experience better symptom control and improved well-being.

4. Side Effects

As with all chemotherapy medications, Pacliaqualip 30mg Injection can cause side effects. Most are manageable and temporary, but some may require medical attention.

Common Side Effects:

• 🔹 Nausea and vomiting

• 🔹 Hair loss (alopecia)

• 🔹 Fatigue and weakness

• 🔹 Diarrhea or constipation

• 🔹 Bone marrow suppression (low blood cell counts)

• 🔹 Peripheral neuropathy (tingling or numbness in hands/feet)

Less Common Side Effects:

• 🔹 Mouth sores

• 🔹 Joint and muscle pain

• 🔹 Abdominal pain

• 🔹 Skin rash or irritation

Serious Side Effects (Seek Immediate Medical Help):

• 🔹 Severe allergic reaction (rash, difficulty breathing, facial swelling)

• 🔹 Chest pain or heart rhythm changes

• 🔹 Infection symptoms (fever, chills, sore throat)

• 🔹 Unusual bleeding or bruising

Always report any unusual or severe side effects to your healthcare provider promptly.

5. Frequently Asked Questions (FAQ)

Q1. What is Pacliaqualip 30mg Injection used for?
A: It is used to treat various cancers such as breast, ovarian, lung, cervical, and pancreatic cancers. It works by stopping the growth and spread of cancer cells.

Q2. How is Pacliaqualip administered?
A: It is given through an intravenous (IV) infusion by a medical professional in a hospital or clinic.

Q3. How often is this injection given?
A: The frequency depends on the type of cancer, overall treatment plan, and the patient’s response. Typically, it is given once every 1–3 weeks.

Q4. Does Pacliaqualip cause hair loss?
A: Yes, temporary hair loss is a common side effect. Hair usually starts to grow back after treatment ends.

Q5. Can I take Pacliaqualip at home?
A: No, it should only be administered by a trained healthcare provider in a clinical setting due to the risk of side effects and the need for monitoring.

References